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occurring in South Korea because
high similarities (98.6%–99.8%) are
found among 4 subspecies of R.
conorii. Multilocus sequence typing
can help differentiate among these
subspecies (6). 
This study provided a model to
amplify SFG rickettsial DNA from
sera of patients, and it will be helpful
in surveillance of these diseases.
However, the results should be inter-
preted more carefully in the context of
clinical and epidemiologic data and
combined with different gene
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To the Editor: Advanced molecu-
lar biologic methods have improved
the species differentiation and taxo-
nomic classification of microorgan-
isms, including nontuberculous
mycobacteria. Identifying and charac-
terizing an increasing number of
“new” mycobacterial species of med-
ical importance is now possible.
Often, these newly described
mycobacteria have been isolated from
immunocompromised patients (1,2).
Some of those have been difficult to
cultivate, and 16S rRNA gene
sequencing or similar methods have
become of major importance to allow
species identification and clinical
diagnosis. Here, we report 2 patients
with disease likely caused by a novel
mycobacterial species that could not
been previously cultivated. Diagnosis
relied on molecular identification of
acid-fast organisms in tissues. We also
briefly review 2 similar cases pub-
lished previously and note that all 4
known patients were from central
Europe.
A 43-year-old woman without evi-
dence of immunodeficiency reported
recurrent episodes of dysuria, hema-
turia, and abdominal discomfort for
>1 year. On cystoscopy, a hyperemic
bladder with yellow plaques was
observed. Biopsy of the plaques
showed granulomatous infiltration of
histiocytes. No definite diagnosis was
made, and symptomatic relief
occurred after a trial of empiric
antimicrobial drug therapy. When the
patient sought treatment again with
persistent abdominal discomfort,
endoscopy showed a lesion in the
stomach that resembled a healed ulcer
and numerous elevated yellow
plaques throughout the colon and
ileum. Microscopically, a granuloma-
tous inflammation with macrophages
filled with many acid-fast rods was
seen, but mycobacterial growth did
not occur in different media or in a
guinea pig. Antituberculous treatment
was initiated, and the patient slowly
improved. A repeat colonoscopy
showed fewer and smaller lesions.
Efforts to culture the organism from
biopsy specimens were again unsuc-
cessful (different solid and liquid
media, blood or chocolate agar,
guinea pig, Balb/c mice). Sequencing
of polymerase chain reaction (PCR)
products of the 16S rRNA gene (3)
from the organism represented a pre-
viously unknown mycobacterial
species (EMBLDNAdatabase: acces-
sion number Z50172). “Mycobac-
terium tilburgii” was proposed as the
designation of this species because
the novel mycobacterium was identi-
fied in the city of Tilburg (4).
Retrospective analysis of the initial
bladder biopsy specimen and of 2
lymph nodes taken during abdominal
surgery (which became necessary
because of a complicating ileal
obstruction) confirmed the presence
of “M. tilburgii” 16S rRNA gene
sequences. All samples yielding PCR
fragments hybridized with a “M.
tilburgii”–specific biotinylated DNA
probe.
A34-year-old AIDS patient sought
treatment for involuntary weight loss.
Endoscopy showed white superficial
embossments of the duodenal
mucosa. Biopsy specimens were neg-
ative for acid-fast bacteria and
mycobacterial growth (again, differ-
ent solid and liquid media, extended
incubation periods). Antiretroviral
therapy was begun, but asthenia, per-
sistent fever, diarrhea, vomiting, and
cachexia developed. Repeat
endoscopy showed yellow, plaquelike
lesions in the duodenum (online
Appendix Figure; available at
http://www.cdc.gov/ncidod/EID/vol1
2no03/05-1139-G1.htm) and esopha-
gus with periodic acid–Schiff (PAS)
and acid-fast intracellular bacteria
that were nonculturable. PCR of 16S
rRNA gene (3) confirmed the pres-
ence of mycobacterial DNA; sequenc-
ing showed 100% homology to the
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species with the proposed name “M.
tilburgii” (4). Retrospectively, “M.
tilburgii” 16S rRNA was present in
the initial duodenal biopsy specimen,
when no mycobacteria were detected
microscopically. Combination thera-
py led to a gradual disappearance of
fever and diarrhea. The patient’s
weight increased, and the lesions dis-
appeared (Table). Control endoscopy
results were unremarkable, although
duodenal biopsy specimens showed
PAS-positive material. Mycobacterial
DNA was no longer detectable.
We believe that the identified acid-
fast organism named “M.  tilburgii”
was the causative agent of illness in
the 2 patients. First, the clinical and
histopathologic appearance of the
lesions is compatible with mycobacte-
rial infection. Second, the finding that
the macrophages in these lesions con-
tained large numbers of acid-fast bac-
teria supports the conclusion that
mycobacterial infection caused the
lesion. Third, the involvement of nor-
mally sterile locations such as lymph
nodes, and the improvement after
antimycobacterial therapy with disap-
pearance of the lesions, acid-fast
organisms, and mycobacterial DNA
supports a causative role of the organ-
ism rather than a bystander role. 
Attempts to culture the organism
from biopsy specimens and resection
materials remained unsuccessful,
although specific requirements for
organisms like M. genavense, a
mycobacterium that also is not cul-
tivable on regular mycobacterial
media (5), were met. Diagnosis there-
fore had to rely on sequencing of PCR
products. Based on 16S rRNAhomol-
ogy, “M. tilburgii” shows close rela-
tionship to M. sherrisii,  a  M.
simiae–related mycobacterium (6)
that probably corresponds to
Mycobacterium strain IWGMT 90143
(accession no. X88906) (7). “M.
tilburgii” also has a high homology to
Mycobacterium  sp. Murphy, a
mycobacterial species that is consid-
ered the cause of canine lepra and that
also has not been cultivated so far (8)
(accession no. AF144747). 
These 2 patients double the num-
ber of patients reported previously
(Table). Both previously reported M.
tilburgii patients had AIDS, 1 of
whom had a disease similar to that of
the second patient in this report (9).
Taken together, 3 patients had gas-
trointestinal involvement with yellow
mucosal plaques (Appendix Figure),
and 1 patient had pulmonary nodules
(10). One of the 4 patients did not
have a detectable immunodeficiency,
yet had gastrointestinal and urinary
bladder lesions. Although complica-
tions occurred, treatment was success-
ful in all 4 cases with usual anti–
Mycobacterium avium complex thera-
py. Interestingly, all 4 patients so far
are of middle-European descent. This
species may be geographically con-
fined, similar to the occurrence of M.
malmoense in which most clinical iso-
lates come from northern Europe (1).  
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